Please login to the form below

Not currently logged in
Email:
Password:

ezetimibe

This page shows the latest ezetimibe news and features for those working in and with pharma, biotech and healthcare.

Esperion craters as deaths mar atherosclerosis drug study

Esperion craters as deaths mar atherosclerosis drug study

earlier phase III trial and the company has reiterated its plans to file for approval as a monotherapy and in combination with Merck &Co/MSD’s Zetia (ezetimibe) in the US

Latest news

More from news
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics